CRF Bracket updates eConsent solution to support virtual studies

By Melissa Fassbender contact

- Last updated on GMT

(Image: Gett/oatawa)
(Image: Gett/oatawa)

Related tags: CRF Bracket, Clinical trial management

CRF Bracket’s eConsent solution now supports remote consenting – as the demand for virtual clinical trials has increased steadily over recent years.

The electronic consent (eConsent) solution, TrialConsent, can integrate with electronic clinical outcome assessment (eCOA) or stand alone.

Jeff Lee, product lead, patient engagement and eConsent at CRF Bracket, said the new secure password-protected login account feature for patients is important. “Optimizing how this gets handled allows for the patient to pause/resume during the consenting process, which is a key patient-centric design feature,”​ he told us.

This login feature – not available on the company's other eConsent systems – eases the patient experience during re-consent, said Lee. He added, “Patients and their families are also given the opportunity to flag any concerns or questions on the documentation and resolve these before providing their consent on a trial.”​  

Since the remote study model was pioneered by Pfizer in 2012, and given “an additional bolt of interest”​ by ResearchKit in 2015, Lee said most initiatives have had “fairly modest ambitions,”​ targeting observational studies “where the expectations for study conduct are more forgiving.”

Still, demand for remote studies has steadily increased over recent years, he said.

“Increasingly, sponsors have come to recognize that fully virtual studies are less realistic. It’s more likely that studies will become ‘semi-virtual,’ where some of the visits are supported remotely, but some still occur at the study site,”​ explained Lee.

He added, “In a way, this realization takes the pressure off the industry to fully resolve challenging issues associated with remotely joining a study, such as how to remotely verify the patient’s identity and direct-to-patient drug supply.”

Lee said this should prompt more use of remote study activities in standard interventional studies. 

“Since we have randomization, eConsent, patient engagement, eCOA, drug supply management, all within a single organization, we feel a responsibility to push ourselves to solve these difficult challenges and help the industry achieve breakthroughs around fully or partially virtual studies,”​ he added.

Moving forward, Lee said the company’s roadmap includes “multiple additional enhancements”​ to its current support of the remote study model.

CRF Bracket recently closed its first full quarter as a combined entity, after the private equity firm behind Bracket purchased​ CRF Health in July 2018. The company saw more than a 20% increase in new clinical trial business​ in the quarter and will “aggressively look for partners” ​from its current and future customers, CEO Mike Nolte told us at the time.

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars